Breaking News

Aesica Names Ops Director

February 5, 2013

Palmer to manage formulated products unit

Jarrett Palmer has been appointed operations director of Aesica’s formulated products business unit. Mr. Palmer has more than 15 years of experience in senior leadership positions and has managed facilities for global CMOs including Catalent Pharma Solutions and Piramal Healthcare.
Mr. Palmer will report to Chris Gowland, managing director of formulated products and will be based at Aesica headquarters in Newcastle, UK. He will manage commercial scale manufacturing, packaging and distribution activities at the company’s Queenborough, UK facility and recently acquired sites in Europe, including Monheim and Zwickau, Germany and Pianezza, Italy.  
“We are delighted to have Jarrett Palmer join Aesica as operations director. He brings significant experience with a long and established track record of managing sites for global CMOs. Jarrett’s role is central to the maintenance of high standards at our FDA approved commercial scale manufacturing sites. He will be critical to the acquisition process and will support senior management in identifying global acquisition targets and transitioning new sites in line with our exacting efficiency and quality standards,” said Mr. Gowland.
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO